Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

Around 22 million Americans have sleep apnea. Traditional continuous positive airway pressure, or CPAP, machines are the standard treatment. However, they can be loud, uncomfortable and have a pesky ...

Biotech firm Apnimed plans to seek FDA approval for its sleep apnea drug, with market availability expected by 2027 ...

A good night's sleep might be an additional benefit some gain from taking weight-loss drugs like Ozempic and Zepbound, a new ...

GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better manage their type 2 diabetes. And as of December 20, Eli Lilly’s weight loss ...

Learn the hidden signs of sleep apnea, its impact on health, and how effective treatment can restore your energy and improve ...

For millions of Americans who struggle with sleep apnea, using a CPAP machine might feel like an inconvenience — the mask feels uncomfortable, the machine makes noise, and keeping it on throughout the ...

Obstructive Sleep Apnea (OSA) is a common but often undiagnosed medical condition affecting many Canadians. Characterized by ...

Research also suggests untreated sleep apnea is linked to a heightened risk of Parkinsons disease, a movement disorder ...

Anyone can develop obstructive sleep apnea (OSA), but there are certain risk factors that can make some people more susceptible to the condition than others. “Obesity, by far, is the main risk factor, ...

The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive sleep apnea. The Food and Drug Administration on Friday authorized the use of Zepbound, made by ...